81 results
PRE 14A
ftd 22hcojhj9z
4 Apr 22
Preliminary proxy
4:15pm
8-K
u8oe1rgt dd3
5 Nov 20
Invitae Reports $68.7 Million in Revenue Driven by 170,000 Samples Accessioned in the Third Quarter of 2020
4:24pm
10-K
hgar fte5g
30 Mar 15
Annual report
12:00am
8-K
EX-99.1
4iyq0juk9kgvl0f ko
11 Jun 21
Invitae appoints technology and medtech veteran Roxi Wen as chief financial officer
8:03am
8-K
mzvfh4m3ep23c
11 Jun 21
Invitae appoints technology and medtech veteran Roxi Wen as chief financial officer
8:03am
8-K
m6oixifuf3wt 0l967hv
11 Dec 23
Entry into a Material Definitive Agreement
4:41pm
8-K
3hrd dcumgg
19 Jul 22
Entry into a Material Definitive Agreement
8:23pm
8-K
EX-99.1
ua65im96xv3u
4 May 21
Invitae Reports $103.6 Million in Revenue Driven by 259,000 in Billable Volume in First Quarter of 2021
4:07pm
424B4
6i0v9h zg
12 Feb 15
Prospectus supplement with pricing info
12:00am
S-1
1xc3kirp4s6 e6eh
9 Jan 15
IPO registration
12:00am
DRS/A
0ed64ou7s50a
11 Dec 14
Draft registration statement (amended)
12:00am
S-1/A
vboqwqii0hmodm88842
2 Feb 15
IPO registration (amended)
12:00am
8-K
EX-3.1
xcgxb5c2 9j
23 Mar 21
Amendments to Articles of Incorporation or Bylaws
4:27pm